Cancer Center Amsterdam
-
Adjuvant chemoradiotherapy versus completion total mesorectal excision after local excision for early rectal cancer (TESAR): a multicentre, randomised, controlled, phase 3, non-inferiority trial
Moolenaar, L. R., Ali, M., Aufenacker, T. J., Beets, G. L., Bosker, R. J. I., Buffart, T. E., Burger, J. W. A., Dekker, E., Denost, Q., Doornebosch, P. G., Duijvendijk, P. V., Fabry, H. F. J., Geijsen, E. D., Gerhards, M. F., van Grevenstein, W. M. U., Grotenhuis, B. A., Hoff, C., Leijtens, J. W. A., Peeters, K. C. M. J. & Pronk, A. & 99 others, , Jul 2026, In: The Lancet Gastroenterology and Hepatology. 11, 7, p. 557-569 13 p.Research output: Contribution to Journal › Article › Academic › peer-review
-
Minimally invasive treatment approaches for early rectal cancer
van Lieshout, A. S., 18 Dec 2025, 232 p.Research output: PhD Thesis › PhD-Thesis - Research and graduation internal
-
Short-term outcomes after primary total mesorectal excision (TME) versus local excision followed by completion TME for early rectal cancer: population-based propensity-matched study
van Lieshout, A. S., Smits, L. J. H., Sijmons, J. M. L., van Dieren, S., van Oostendorp, S. E., Tanis, P. J. & Tuynman, J. B., 1 Oct 2024, In: BJS Open. 8, 5, zrae103.Research output: Contribution to Journal › Article › Academic › peer-review
- All publications